Arch Biopartners Inc (FOIFF) 0.2733 $FOIFF
Arch Biopartners 2015 AGM Results and Technology Status Update
Marketwired - Wed Apr 01, 8:40AM CDT
Arch Biopartners Inc ("Arch"

or the "Company"

(TSX VENTURE: ACH) and (OTCBB: FOIFF) announced results from its Annual General Meeting of Shareholders held in Toronto on March 30, 2015. Shareholders voted in favour of all items put forward to them by management and the Board.
ACH.VN: 0.320 (-0.025), ACH: 15.85 (-0.48)
Arch Biopartners Identifies Candidate Drug to Treat Psuedomonas Respiratory Infections
Marketwired - Wed Mar 18, 8:45AM CDT
Arch Biopartners Inc ("Arch"

or the "Company"

(TSX VENTURE: ACH) and (OTCBB: FOIFF) announced today it has identified a new candidate drug to treat Pseudomonas aeruginosa respiratory infections. This new drug is the result of development work performed during 2014 and early 2015 by Dr. Daniel Hassett at the University of Cincinnati ("UC"

.
ACH.VN: 0.320 (-0.025), ACH: 15.85 (-0.48)
Surrey Capital Corp. Signs Letter of Intent to Acquire 100% Of Mobilman
Filing Services Canada XHTML - Thu Jan 15, 7:37AM CST
MDSY: 2.27 (unch), BBY: 35.09 (+0.50), SYC.VN: 0.020 (-0.005), VDR.VN: 0.020 (-0.005), LMS.VN: 0.750 (-0.070)